Larry J. Anderson American virologist
Anderson, Larry J.
Anderson, L.J.
Anderson, L.J. (Larry J.)
VIAF ID: 199800406 (Personal)
Permalink: http://viaf.org/viaf/199800406
Preferred Forms
- 200 _ | ‡a Anderson ‡b Larry J.
-
-
- 100 1 _ ‡a Anderson, L.J.
-
- 100 1 _ ‡a Anderson, Larry J.
- 100 1 _ ‡a Anderson, Larry J.
- 100 1 0 ‡a Anderson, Larry J.
-
-
- 100 0 _ ‡a Larry J. Anderson ‡c American virologist
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines | |
Human parvovirus B19, 1997: | |
Molecular detection of adenoviruses, rhabdoviruses, and paramyxoviruses in bats from Kenya | |
Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000 | |
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins | |
Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus | |
Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk | |
National surveillance of Kawasaki disease. | |
Nipah virus: a recently emergent deadly paramyxovirus | |
Nonclassic measles infections in an immune population exposed to measles during a college bus trip | |
Norwalk virus antigen and antibody response in an adult volunteer study | |
Novel human rhinoviruses and exacerbation of asthma in children | |
Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE). | |
Outbreak of echovirus 11 infection in hospitalized neonates | |
Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia | |
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. | |
Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. | |
Parvovirus B19 infection in hospital workers: community or hospital acquisition? | |
A passive quantitative measurement of airway resistance using depth data | |
Pathologic Studies of Fatal Cases in Outbreak of Hand, Foot, and Mouth Disease, Taiwan | |
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | |
Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics | |
Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection | |
Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study | |
Pharyngoconjunctival Fever Caused by Adenovirus Type 4: Report of a Swimming Pool-Related Outbreak with Recovery of Virus from Pool Water | |
Population biology, evolution, and immunology of vaccination and vaccination programs. | |
Possible transmission of parvovirus B19 from intravenous immune globulin | |
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. | |
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. | |
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association | |
Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique | |
Prevalence of viral respiratory tract infections in children with asthma. | |
Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. | |
Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. | |
Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015 | |
Prophylaxis for persons in contact with patients who have rabies | |
Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice | |
Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells | |
Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles | |
Quantification of respiratory syncytial virus polypeptides in nasal secretions by monoclonal antibodies | |
Rabies diagnosis and rabies vaccine | |
Rapid antibody response to human diploid rabies vaccine | |
Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assay | |
Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. | |
Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus | |
Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins | |
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). | |
Refractory status epilepticus in suspect encephalitis | |
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. | |
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. | |
A respiratory syncytial virus attachment (G) gene variant associated with more severe disease in infants decreases fusion (F) protein expression which may facilitate immune evasion | |
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses | |
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice | |
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults | |
Respiratory syncytial virus outbreak on American Samoa. Evaluation of risk factors | |
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden | |
Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene | |
Response to rhinovirus infection by human airway epithelial cells and peripheral blood mononuclear cells in an in vitro two-chamber tissue culture system | |
A Vision-Based Respiration Monitoring System for Passive Airway Resistance Estimation |